CU Medical Systems, Inc. (KOSDAQ:115480)
587.00
+3.00 (0.51%)
At close: Jan 23, 2026
CU Medical Systems Market Cap
CU Medical Systems has a market cap or net worth of 35.53 billion as of January 23, 2026. Its market cap has decreased by -14.43% in one year.
Market Cap
35.53B
Enterprise Value
42.91B
Revenue
44.79B
Ranking
n/a
PE Ratio
n/a
Stock Price
587.00
Market Cap Chart
Since December 15, 2011, CU Medical Systems's market cap has decreased from 87.97B to 35.53B, a decrease of -59.61%. That is a compound annual growth rate of -6.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 35.53B | 6.73% |
| Dec 30, 2025 | 33.29B | -18.15% |
| Dec 30, 2024 | 40.67B | -0.92% |
| Dec 28, 2023 | 41.05B | -31.05% |
| Dec 29, 2022 | 59.54B | 15.44% |
| Dec 30, 2021 | 51.58B | -22.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Remed | 86.39B |
| Hironic | 74.74B |
| JPI Healthcare | 73.01B |
| DRGEM | 59.38B |
| Neofect | 52.19B |
| Genoray | 51.20B |
| UXN Co., Ltd. | 40.50B |
| Genesystem | 33.25B |